Q2 2021 Inovio Pharmaceuticals Inc Earnings Call Transcript
Good afternoon, and welcome to the INOVIO Second Quarter 2021 Financial Results Conference Call. (Operator Instructions) Please note, this event is being recorded.
I would now like to turn the conference over to Ben Matone, Senior Director of Investor Relations. Please go ahead.
Thank you, operator. Good afternoon, and thank you for joining the INOVIO Second Quarter 2021 Earnings Conference Call. Joining me on today's call are Dr. Joseph Kim, President and CEO; Mr. Peter Kies, CFO; Dr. Jacqui Shea, Chief Operating Officer; Dr. Laurent Humeau, Chief Scientific Officer; Dr. Anza Mammen, Senior Vice President of Clinical Development; and Dr. Kate Broderick, Senior Vice President of Research and Development.
For today's call, we will review our corporate and financial information for the second quarter ended June 30, 2021. We will discuss our COVID-19 vaccine development efforts that address both current and future variants of concern as well as recent developments associated with INOVIO's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |